Z3 Capital Partners, LLC has filed its Form 13F-HR for the period ending September 30, 2026, disclosing ownership of 191 equity securities. The filing, signed by Chief Compliance Officer James Hadaway, details the firm's portfolio composition as of the specified date.
The report lists a diverse mix of common stocks, exchange-traded funds, and closed-end funds. Major technology and artificial intelligence companies appear prominently in the holdings, including Palantir Technologies Incorporated Class A, NVIDIA Corporation, and Micron Technology Incorporated. The portfolio also includes significant positions in Alphabet Inc. Class A, Microsoft Corporation, and Amazon.com Incorporated.
Outside of the technology sector, the filing reveals substantial stakes in energy and healthcare companies. ClearBridge Energy Midstream O, Chevron Corporation, Dominion Energy Incorporated, and Enterprise Products Partners L P are listed among the energy-related holdings. Healthcare exposure is represented by Eli Lilly & Company, AbbVie Incorporated, Merck & Company Incorporated, and Bristol-Myers Squibb Company.
Z3 Capital also holds various exchange-traded funds, including the SPDR S&P 500 ETF Trust, the Invesco QQQ Trust, and multiple BlackRock funds focused on science, technology, and healthcare. Additionally, the firm lists positions in financial institutions such as JPMorgan Chase & Company, Visa Inc. Class A, and Mastercard Incorporated Class A.
